Loading data
NIONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 12.51 bn USD | 9.01 bn USD | 7.83 bn USD | 7.14 bn USD |
| Cost of revenue | 10.81 bn USD | 8.12 bn USD | 7.4 bn USD | 6.4 bn USD |
| Gross profit | 1.7 bn USD | 889.51 m USD | 429.84 m USD | 745.81 m USD |
| Research and development expense | 1.52 bn USD | 1.79 bn USD | 1.89 bn USD | 1.57 bn USD |
| Selling, general and administrative expense | 2.3 bn USD | 2.16 bn USD | 1.81 bn USD | 1.53 bn USD |
| Operating profit | -2.01 bn USD | -3 bn USD | -3.19 bn USD | -2.27 bn USD |
| Interest expense | 126.59 m USD | 109.38 m USD | 56.84 m USD | 48.31 m USD |
| Profit before tax | -2.12 bn USD | -3.07 bn USD | -2.88 bn USD | -2.09 bn USD |
| Income tax expense | 17.43 m USD | -3.13 m USD | 36.74 m USD | 7.99 m USD |
| Net income (reported basis) | -2.14 bn USD | -3.07 bn USD | -2.92 bn USD | -2.09 bn USD |
| Net income attributable to common shareholders | -2.23 bn USD | -3.1 bn USD | -2.98 bn USD | -2.11 bn USD |
| Basic earnings per share | -0.98 USD/share | -1.51 USD/share | -1.75 USD/share | -1.29 USD/share |
| Diluted earnings per share | -0.98 USD/share | -1.51 USD/share | -1.75 USD/share | -1.29 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.